InnovAge (INNV) Projected to Announce Earnings on Tuesday

Key Points

• InnovAge is expected to report Q4 2026 results after the market closes on Tuesday, September 8, with analysts projecting earnings of $0.0747 per share and revenue of $238.3 million.
• Shares opened at $10.80, with the stock trading between a 12-month low of $3.54 and high of $12.64; InnovAge has a market capitalization of approximately $1.47 billion.
• Analyst sentiment remains cautious: InnovAge has a consensus “Reduce” rating and a $10.00 target price, despite KeyCorp upgrading the stock to “overweight” with a $13.00 target. Institutional investors own 12.26% of the company.

InnovAge (NASDAQ:INNV - Get Free Report) is expected to be announcing its Q4 2026 results after the market closes on Tuesday, September 8th. Analysts expect InnovAge to post earnings of $0.0747 per share and revenue of $238.3340 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q4 2026 earning results page for the latest details on the call scheduled for Tuesday, September 8, 2026 at 5:00 PM ET.

InnovAge Price Performance

Shares of InnovAge stock opened at $10.80 on Tuesday. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $1.47 billion, a price-to-earnings ratio of -120.00 and a beta of 0.39. InnovAge has a twelve month low of $3.54 and a twelve month high of $12.64. The company has a 50-day simple moving average of $11.18 and a two-hundred day simple moving average of $9.22.

Hedge Funds Weigh In On InnovAge

Several hedge funds have recently bought and sold shares of the company. CIBC Asset Management Inc acquired a new position in shares of InnovAge in the 4th quarter valued at approximately $57,000. Invesco Ltd. acquired a new stake in shares of InnovAge during the 4th quarter worth approximately $57,000. Deutsche Bank AG boosted its position in shares of InnovAge by 15.1% during the 4th quarter. Deutsche Bank AG now owns 12,775 shares of the company's stock worth $66,000 after acquiring an additional 1,679 shares in the last quarter. Bank of America Corp DE increased its stake in InnovAge by 42.4% in the fourth quarter. Bank of America Corp DE now owns 19,945 shares of the company's stock valued at $78,000 after acquiring an additional 5,936 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in InnovAge by 26.0% in the third quarter. JPMorgan Chase & Co. now owns 15,993 shares of the company's stock valued at $83,000 after acquiring an additional 3,305 shares during the last quarter. 12.26% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on INNV shares. KeyCorp raised shares of InnovAge from a "sector weight" rating to an "overweight" rating and set a $13.00 target price on the stock in a report on Friday, August 21st. Wall Street Zen cut InnovAge from a "buy" rating to a "hold" rating in a research note on Sunday, May 17th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of InnovAge in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, InnovAge currently has a consensus rating of "Reduce" and a consensus target price of $10.00.

About InnovAge

InnovAge Holdings, Inc NASDAQ: INNV is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants' homes and community-based centers. InnovAge's approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company's core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source